• Register
  • Login
  • Subscribe
  • Contact Us

Latest Lisinopril Tenders in Kazakh 2025

KazakhTenders brings you the latest and most relevant Lisinopril tenders in Kazakh, sourced directly from reliable government portals, purchaser websites, and leading procurement publications. Whether you're a supplier, contractor, or manufacturer, we ensure you stay informed about ongoing bidding opportunities without missing a beat.

Our platform is regularly updated with tenders related to Lisinopril and other keywords tenders. Each listing includes key details such as tender reference numbers, submission deadlines, and purchaser information helping you make informed bidding decisions quickly and confidently.

By subscribing to KazakhTenders, users gain unlimited access to public procurement notices related to Lisinopril. Our tools also offer category-based filtering, email alerts, and quick tender downloads, making your bidding process faster and more efficient. Stay ahead of the competition and grow your business by exploring verified tenders from both government and private entities across Kazakh.

Purchase of Medicines and other Medical Supplies, Amt: 222553.80

KZT Ref No.:  130399968

Deadline:  19 Nov 2025

Advertisement for the Purchase of Goods, Amt: 404637.44

KZT Ref No.:  127993832

Deadline:  14 Oct 2025

Medicines According to the Customs Union, Amt: 4948875.00

KZT Ref No.:  127940542

Deadline:  13 Oct 2025

Acquisition of Medicines and Medical Devices, Amt: 288665.23

KZT Ref No.:  124357166

Deadline:  13 Aug 2025

Acquisition of Drugs and Medical Devices, Amt: 319125.23

KZT Ref No.:  123788458

Deadline:  05 Aug 2025

Acquisition of Medicines and Medical Devices, Amt: 1195933.46

KZT Ref No.:  123477875

Deadline:  30 Jul 2025

Acquisition of Drugs, Amt: 577636.00

KZT Ref No.:  121631149

Deadline:  27 Jun 2025

Acquisition of Drugs, Amt: 417395.00

KZT Ref No.:  121028652

Deadline:  19 Jun 2025

Acquisition of Medicines and Medical Devices, Amt: 58198.80

KZT Ref No.:  119848935

Deadline:  29 May 2025

  Chat with us